PRIMARY MYELOFIBROSIS (PMF)
Clinical trials for PRIMARY MYELOFIBROSIS (PMF) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY MYELOFIBROSIS (PMF) trials appear
Sign up with your email to follow new studies for PRIMARY MYELOFIBROSIS (PMF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for rare blood cancer in japan
Disease control Not yet recruitingThis small, early-stage study aims to check if adding a new drug called pelabresib to a standard medication (ruxolitinib) is safe for Japanese adults with myelofibrosis, a rare and serious bone marrow cancer. It will involve about 6 participants who are already taking a stable do…
Matched conditions: PRIMARY MYELOFIBROSIS (PMF)
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for blood cancer patients: Two-Drug combo enters final testing
Disease control Not yet recruitingThis study is testing whether adding a new drug called pelabresib to the standard treatment (ruxolitinib) works better for adults with myelofibrosis, a serious bone marrow cancer. It will enroll 460 patients who have not yet tried JAK inhibitor drugs. The main goals are to see if…
Matched conditions: PRIMARY MYELOFIBROSIS (PMF)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC